HUP0203805A3 - Ox2 receptor homologs - Google Patents

Ox2 receptor homologs

Info

Publication number
HUP0203805A3
HUP0203805A3 HU0203805A HUP0203805A HUP0203805A3 HU P0203805 A3 HUP0203805 A3 HU P0203805A3 HU 0203805 A HU0203805 A HU 0203805A HU P0203805 A HUP0203805 A HU P0203805A HU P0203805 A3 HUP0203805 A3 HU P0203805A3
Authority
HU
Hungary
Prior art keywords
receptor homologs
homologs
receptor
Prior art date
Application number
HU0203805A
Other languages
English (en)
Original Assignee
Medical Res Council
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9911123.9A external-priority patent/GB9911123D0/en
Priority claimed from GBGB9925989.7A external-priority patent/GB9925989D0/en
Application filed by Medical Res Council, Schering Corp filed Critical Medical Res Council
Publication of HUP0203805A2 publication Critical patent/HUP0203805A2/hu
Publication of HUP0203805A3 publication Critical patent/HUP0203805A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
HU0203805A 1999-05-13 2000-05-11 Ox2 receptor homologs HUP0203805A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9911123.9A GB9911123D0 (en) 1999-05-13 1999-05-13 Materials and methods relating to a membrane-bound cell surface protein
GBGB9925989.7A GB9925989D0 (en) 1999-11-03 1999-11-03 Mammalian proteins; related reagents and methods
PCT/US2000/012998 WO2000070045A1 (en) 1999-05-13 2000-05-11 Ox2 receptor homologs

Publications (2)

Publication Number Publication Date
HUP0203805A2 HUP0203805A2 (hu) 2003-03-28
HUP0203805A3 true HUP0203805A3 (en) 2012-09-28

Family

ID=26315542

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203805A HUP0203805A3 (en) 1999-05-13 2000-05-11 Ox2 receptor homologs

Country Status (13)

Country Link
US (3) US20060084121A1 (hu)
EP (3) EP2341143A1 (hu)
JP (3) JP2002543838A (hu)
KR (5) KR101018176B1 (hu)
CN (1) CN1372594A (hu)
AU (1) AU5007200A (hu)
CA (1) CA2372549A1 (hu)
HK (1) HK1044023A1 (hu)
HU (1) HUP0203805A3 (hu)
IL (1) IL146417A0 (hu)
MX (1) MXPA01011519A (hu)
NZ (1) NZ515382A (hu)
WO (1) WO2000070045A1 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166188A1 (en) * 1997-09-18 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1683865A3 (en) * 2001-02-02 2006-10-25 Eli Lilly & Company Mammalian proteins and in particular CD200
WO2002088164A1 (en) 2001-04-26 2002-11-07 Immunex Corporation Human ox2 receptors
CA2448668A1 (en) * 2001-05-24 2002-11-28 Trillium Therapeutics Inc. Modulation of cd200 receptors
EP1439857B1 (en) 2001-10-12 2009-02-25 Schering Corporation USE OF BISPECIFIC ANTIBODIES BINDING TO THE ACTIVATING RECEPTOR FcEpsilonRI AND TO THE INHIBITING RECEPTOR OX2Ra (CD200Ra) TO REGULATE IMMUNE RESPONSES
WO2003077947A1 (en) * 2002-03-15 2003-09-25 Schering Corporation Methods of modulating cd200 receptors
EP1585545A4 (en) * 2002-12-27 2006-04-12 Schering Corp PROCESS FOR INDUCING AND MAINTAINING IMMUNE COMPATIBILITY
WO2004072648A1 (en) * 2003-02-17 2004-08-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor ox2r (ox2r)
JP2010512791A (ja) 2006-12-22 2010-04-30 シェーリング コーポレイション Ｃｄ２００ｒに対する抗体
US8585870B2 (en) * 2008-03-05 2013-11-19 E I Du Pont De Nemours And Company Process to C-manufacture acrylonitrile and hydrogen cyanide
BR112022024339A2 (pt) * 2020-05-29 2022-12-27 23Andme Inc Anticorpos anti cd200r1 e métodos de uso dos mesmos

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US213783A (en) * 1879-04-01 Improvement in hot-air engines
US169870A (en) * 1875-11-09 Improvement in potato-diggers
US244052A (en) * 1881-07-12 Railroad-gate
US223991A (en) * 1880-02-03 Parent office
GB1319315A (en) 1969-06-19 1973-06-06 Citizen Watch Co Ltd Calendar timepiece
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
EP1100869A4 (en) * 1998-07-30 2005-04-27 Human Genome Sciences Inc 98 HUMAN SECRETED PROTEINS
US20030166132A1 (en) * 1998-08-26 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU6802801A (en) * 2000-03-01 2001-09-24 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2003077947A1 (en) * 2002-03-15 2003-09-25 Schering Corporation Methods of modulating cd200 receptors
EP1585545A4 (en) * 2002-12-27 2006-04-12 Schering Corp PROCESS FOR INDUCING AND MAINTAINING IMMUNE COMPATIBILITY
US20070244052A1 (en) * 2003-12-19 2007-10-18 Schering Corporation Methods for Identifying Agonists or Antagonists of CD200R Signaling Molecules and Methods of Using the Same
JP2007518827A (ja) * 2004-02-02 2007-07-12 シェーリング　コーポレイション Ｃｄ２００およびｃｄ２００ｒを調節する方法
JP2010512791A (ja) * 2006-12-22 2010-04-30 シェーリング コーポレイション Ｃｄ２００ｒに対する抗体
US11068393B2 (en) 2019-10-17 2021-07-20 Microsoft Technology Licensing, Llc Enhanced concurrency garbage collection stack scanning

Also Published As

Publication number Publication date
US20060084121A1 (en) 2006-04-20
JP2007319163A (ja) 2007-12-13
KR101018176B1 (ko) 2011-02-28
EP2341143A1 (en) 2011-07-06
KR20090133133A (ko) 2009-12-31
KR101005124B1 (ko) 2011-01-04
NZ515382A (en) 2004-03-26
HK1044023A1 (zh) 2002-10-04
JP2012072186A (ja) 2012-04-12
KR20110102476A (ko) 2011-09-16
IL146417A0 (en) 2002-07-25
WO2000070045A1 (en) 2000-11-23
KR20100123890A (ko) 2010-11-25
KR20090025341A (ko) 2009-03-10
US20090012270A1 (en) 2009-01-08
US20120231003A1 (en) 2012-09-13
CN1372594A (zh) 2002-10-02
CA2372549A1 (en) 2000-11-23
JP2002543838A (ja) 2002-12-24
HUP0203805A2 (hu) 2003-03-28
KR20020047036A (ko) 2002-06-21
KR101018134B1 (ko) 2011-02-25
EP2336321A1 (en) 2011-06-22
EP1177295A1 (en) 2002-02-06
AU5007200A (en) 2000-12-05
MXPA01011519A (es) 2003-08-20

Similar Documents

Publication Publication Date Title
EP1189609A4 (en) CXCR-4 RECEPTOR ANTAGONISTS AND THROMBOPOIETIN MIMETIKA
GB0015176D0 (en) Early entry
GB0016917D0 (en) Early entry
EP1151955A4 (en) ELEVATOR DEVICE
IL144875A0 (en) Receptor assay
IL146151A0 (en) Human-g-protein receptor
HUP0203805A3 (en) Ox2 receptor homologs
EG24025A (en) Vitronectin receptor antagonist
IL154654A0 (en) Osteoclast-associated receptor
EP1084142A4 (en) GPR35A RECEIVER
GB0025045D0 (en) Early Entry
AU1252102A (en) Receptor
GB0000474D0 (en) Receptor
EP1223946A4 (en) HUMAN NEUROPEPTIDE RECEPTOR
IL154317A0 (en) Imidazoline receptor homologs
GB9927215D0 (en) Hormone receptor expression
GB0007274D0 (en) Lavatories
GB0023554D0 (en) Early entry
GB0031096D0 (en) Receptor
GB0110662D0 (en) Receptor
GB0111959D0 (en) Receptor
GB0114929D0 (en) Receptor
GB0125183D0 (en) Receptor
EP1109565A4 (en) GABAB1AA RECEPTOR
GB0107914D0 (en) 7tm receptor hlwar77

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished